• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

影像学在多发性骨髓瘤管理中的关键作用

The Critical Role of Imaging in the Management of Multiple Myeloma.

作者信息

Raza Shahzad, Leng Siyang, Lentzsch Suzanne

机构信息

Division of Hematology/Oncology, Columbia University Medical Center, Herbert Irving Pavilion, 161 Fort Washington Ave, New York, NY, 10032, USA.

出版信息

Curr Hematol Malig Rep. 2017 Jun;12(3):168-175. doi: 10.1007/s11899-017-0379-9.

DOI:10.1007/s11899-017-0379-9
PMID:28317080
Abstract

Multiple myeloma (MM) is characterized by abnormal proliferation of plasma cells in the bone marrow leading to symptoms of anemia, renal failure, hypercalcemia, and bone lesions. Bone imaging is critical for the diagnosis, staging, assessment for the presence and extent of bone lesions, and initial treatment of MM. Skeletal survey is the preferred initial imaging modality due to its availability and low cost. However, it has poor sensitivity and patients with occult myeloma may escape detection, delaying their diagnosis and treatment. New cross-sectional imaging modalities such as low-dose whole body CT, MRI, and PET-CT have high sensitivity and specificity for detecting lytic lesions and extramedullary relapse in MM. The combined use of cross-sectional imaging may provide complimentary information for staging, prognosis, and disease monitoring. In this review, we will discuss commonly used imaging modalities and their advantages and disadvantages in the management of MM.

摘要

多发性骨髓瘤(MM)的特征是骨髓中浆细胞异常增殖,导致贫血、肾衰竭、高钙血症和骨病变等症状。骨成像对于MM的诊断、分期、评估骨病变的存在和范围以及初始治疗至关重要。骨骼X线检查因其可及性和低成本而成为首选的初始成像方式。然而,其敏感性较差,隐匿性骨髓瘤患者可能无法被检测到,从而延误诊断和治疗。新的断层成像方式,如低剂量全身CT、MRI和PET-CT,对检测MM中的溶骨性病变和髓外复发具有高敏感性和特异性。联合使用断层成像可为分期、预后和疾病监测提供补充信息。在本综述中,我们将讨论MM管理中常用的成像方式及其优缺点。

相似文献

1
The Critical Role of Imaging in the Management of Multiple Myeloma.影像学在多发性骨髓瘤管理中的关键作用
Curr Hematol Malig Rep. 2017 Jun;12(3):168-175. doi: 10.1007/s11899-017-0379-9.
2
Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.全身低剂量计算机断层扫描和多发性骨髓瘤骨病的高级成像技术。
Clin Cancer Res. 2014 Dec 1;20(23):5888-97. doi: 10.1158/1078-0432.CCR-14-1692. Epub 2014 Oct 7.
3
Multiple Myeloma Guidelines and Their Recent Updates: Implications for Imaging.多发性骨髓瘤指南及其近期更新:对影像学的影响
Rofo. 2019 Nov;191(11):998-1009. doi: 10.1055/a-0897-3966. Epub 2019 May 28.
4
[Imaging techniques in multiple myeloma].[多发性骨髓瘤的影像学技术]
Nihon Rinsho. 2007 Dec;65(12):2261-7.
5
State of the art imaging of multiple myeloma: comparative review of FDG PET/CT imaging in various clinical settings.多发性骨髓瘤的前沿成像:不同临床环境中FDG PET/CT成像的比较综述
Eur J Radiol. 2014 Dec;83(12):2203-2223. doi: 10.1016/j.ejrad.2014.09.012. Epub 2014 Sep 28.
6
Imaging patients with myeloma.对骨髓瘤患者进行成像检查。
Clin Radiol. 2009 Jan;64(1):1-11. doi: 10.1016/j.crad.2008.07.006. Epub 2008 Aug 29.
7
PET Imaging for Initial Staging and Therapy Assessment in Multiple Myeloma Patients.正电子发射断层显像用于多发性骨髓瘤患者的初始分期和治疗评估
Int J Mol Sci. 2017 Feb 18;18(2):445. doi: 10.3390/ijms18020445.
8
PET/CT and MR imaging in myeloma.骨髓瘤的正电子发射断层显像/计算机断层扫描(PET/CT)与磁共振成像(MR)
Skeletal Radiol. 2007 Jan;36(1):5-16. doi: 10.1007/s00256-006-0184-3. Epub 2006 Aug 17.
9
The role of imaging techniques in the management of multiple myeloma.影像学技术在多发性骨髓瘤治疗中的作用。
Br J Haematol. 2012 Dec;159(5):499-513. doi: 10.1111/bjh.12007. Epub 2012 Aug 11.
10
[The importance of imaging techniques in the modern treatment of multiple myeloma].[成像技术在多发性骨髓瘤现代治疗中的重要性]
Przegl Lek. 2014;71(4):221-30.

引用本文的文献

1
Current Status and Future of Artificial Intelligence in MM Imaging: A Systematic Review.人工智能在骨髓瘤成像中的现状与未来:一项系统综述。
Diagnostics (Basel). 2023 Nov 2;13(21):3372. doi: 10.3390/diagnostics13213372.
2
Response-Adapted Therapy for Newly Diagnosed Multiple Myeloma.新诊断多发性骨髓瘤的应答适应性治疗。
Curr Hematol Malig Rep. 2023 Oct;18(5):190-200. doi: 10.1007/s11899-023-00704-9. Epub 2023 Jul 4.
3
Improvement in the Symptoms and VEGF Levels after Resection of an Extrame Dullary Spinal Tumor and Additional Chemotherapy in a Patient with Multiple Myeloma Complicated with POEMS Syndrome.

本文引用的文献

1
Nuclear medicine imaging of multiple myeloma, particularly in the relapsed setting.多发性骨髓瘤的核医学成像,尤其是在复发情况下。
Eur J Nucl Med Mol Imaging. 2017 Feb;44(2):332-341. doi: 10.1007/s00259-016-3576-1. Epub 2016 Nov 29.
2
International Myeloma Working Group consensus criteria for response and minimal residual disease assessment in multiple myeloma.国际骨髓瘤工作组多发性骨髓瘤反应和微小残留病评估的共识标准。
Lancet Oncol. 2016 Aug;17(8):e328-e346. doi: 10.1016/S1470-2045(16)30206-6.
3
MRI in multiple myeloma: a pictorial review of diagnostic and post-treatment findings.
多发性骨髓瘤合并 POEMS 综合征患者在切除髓外脊髓肿瘤和接受辅助化疗后症状和 VEGF 水平改善。
Intern Med. 2021;60(22):3625-3630. doi: 10.2169/internalmedicine.6929-20. Epub 2021 Nov 15.
4
Comprehensive Updates in the Role of Imaging for Multiple Myeloma Management Based on Recent International Guidelines.基于近期国际指南的多发性骨髓瘤管理中影像学作用的综合更新。
Korean J Radiol. 2021 Sep;22(9):1497-1513. doi: 10.3348/kjr.2020.0886.
5
Copper 64-labeled daratumumab as a PET/CT imaging tracer for multiple myeloma.铜 64 标记的达妥木单抗作为多发性骨髓瘤的 PET/CT 成像示踪剂。
Blood. 2018 Feb 15;131(7):741-745. doi: 10.1182/blood-2017-09-807263. Epub 2018 Jan 4.
多发性骨髓瘤的磁共振成像:诊断及治疗后表现的影像综述
Insights Imaging. 2016 Aug;7(4):553-69. doi: 10.1007/s13244-016-0492-7. Epub 2016 May 10.
4
18F-fluorocholine versus 18F-fluorodeoxyglucose for PET/CT imaging in patients with suspected relapsing or progressive multiple myeloma: a pilot study.18F-氟胆碱与18F-氟脱氧葡萄糖用于疑似复发或进展性多发性骨髓瘤患者的PET/CT成像:一项初步研究。
Eur J Nucl Med Mol Imaging. 2016 Oct;43(11):1995-2004. doi: 10.1007/s00259-016-3392-7. Epub 2016 Apr 28.
5
Comparison of (18)F-FDG PET/CT and PET/MRI in patients with multiple myeloma.18F-FDG PET/CT与PET/MRI在多发性骨髓瘤患者中的比较。
Am J Nucl Med Mol Imaging. 2015 Oct 12;5(5):469-78. eCollection 2015.
6
State-of-the-art of bone marrow imaging in multiple myeloma.多发性骨髓瘤的骨髓成像技术现状
Curr Opin Oncol. 2015 Nov;27(6):540-50. doi: 10.1097/CCO.0000000000000230.
7
International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma.国际骨髓瘤工作组更新了多发性骨髓瘤的诊断标准。
Lancet Oncol. 2014 Nov;15(12):e538-48. doi: 10.1016/S1470-2045(14)70442-5. Epub 2014 Oct 26.
8
Whole-body low-dose computed tomography and advanced imaging techniques for multiple myeloma bone disease.全身低剂量计算机断层扫描和多发性骨髓瘤骨病的高级成像技术。
Clin Cancer Res. 2014 Dec 1;20(23):5888-97. doi: 10.1158/1078-0432.CCR-14-1692. Epub 2014 Oct 7.
9
¹⁸F-FDG PET/CT: a review of diagnostic and prognostic features in multiple myeloma and related disorders.¹⁸F-FDG PET/CT:多发性骨髓瘤及相关疾病的诊断和预后特征综述
Clin Exp Med. 2015 Feb;15(1):1-18. doi: 10.1007/s10238-014-0308-3. Epub 2014 Sep 14.
10
Bone disease in multiple myeloma: pathophysiology and management.多发性骨髓瘤中的骨病:病理生理学与管理
Cancer Growth Metastasis. 2014 Aug 10;7:33-42. doi: 10.4137/CGM.S16817. eCollection 2014.